No difference in function between stem cells and control during microfracture
Transplantation of autologous bone marrow-derived mesenchymal stem cells under arthroscopic surgery with microfracture versus microfracture alone for articular cartilage lesions in the knee: A multicenter prospective randomized control clinical trialRegen Ther. 2019;(11):106-113. doi: 10.1016/j.reth.2019.06.002
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
The authors randomized 14 patients who were undergoing microfracture to two groups: one group received bone marrow-derived mesenchymal stem cells (BMSCs), and the other group were controls. Outcomes included the Knee Injury and Osteoarthritis Outcome Score (KOOS), the International Knee Documentation Committee (IKDC), T2 time on magnetic resonance imaging, and the Magnetic Resonance Observation Ca...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE